Glycaemic Response to a Liquid Meal Tolerance Test

This study has been completed.
Sponsor:
Collaborator:
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc.
ClinicalTrials.gov Identifier:
NCT01682174
First received: September 6, 2012
Last updated: May 7, 2013
Last verified: May 2013
  Purpose

The purpose of this study is to assess whether added food ingredient(s) affect glycaemic responses to a liquid meal tolerance test (LMTT).


Condition Intervention
Glycaemic Index
Glycaemic Response
Other: Control Drink
Other: Experimental Drink

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Effects of Dehydrated Vegetable Powder on Glycaemic Responses to a Liquid Meal Tolerance Test (LMTT)

Further study details as provided by Mondelēz International, Inc.:

Primary Outcome Measures:
  • Glycaemic response (incremental area under the curve) of experimental test food using capillary blood [ Time Frame: 120 minutes ] [ Designated as safety issue: No ]

Enrollment: 13
Study Start Date: September 2012
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control Test Drink
control drink
Other: Control Drink Other: Experimental Drink
Experimental: Experimental Test Drink
Experimental Drink
Other: Control Drink Other: Experimental Drink

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Male or female (not less than 40% Male)
  2. Aged 18 - 55 years
  3. Non Smokers
  4. Have a body mass index between 18.5 to 29.99 kg/m2
  5. Healthy, non-diabetic, no gastric bypass surgery
  6. Not allergic to dairy, or soy
  7. Have a fasting plasma glucose (finger-stick) <100 mg/dl (<5.5 mmol/L)
  8. Willing and able to provide written informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01682174

Locations
United Kingdom
Reading Scientific Services Limited (RSSL)
Reading, Berkshire, United Kingdom
Sponsors and Collaborators
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Investigators
Principal Investigator: Rungano Munyuki RSSL
  More Information

No publications provided

Responsible Party: Mondelēz International, Inc.
ClinicalTrials.gov Identifier: NCT01682174     History of Changes
Other Study ID Numbers: P12-05775
Study First Received: September 6, 2012
Last Updated: May 7, 2013
Health Authority: United Kingdom: Research Ethics Committee

ClinicalTrials.gov processed this record on October 20, 2014